In compliance to Regulation 33 read with Regulation 30 along with Part A of Schedule 111 of SEBl Listing Regulations, 2015, Fredun Pharmaceuticals has informed that the Board of Directors of the Company, at its Meeting held on Monday, June 18, 2018, have considered and approved the Audited Financials for the year ended March 31, 2018.
The above information is a part of company’s filings submitted to BSE.